Blake Borgeson's Insider Trades & SAST Disclosures
Blake Borgeson's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 1,734 Class A Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Blake Borgeson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,734 | 7,067,847 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 12 Nov 2024 | 11,447 | 7,066,113 | - | 7.6 | 87,457 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.72 per share. | 29 Oct 2024 | 11,447 | 7,077,560 | - | 6.7 | 76,926 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.67 per share. | 15 Oct 2024 | 11,447 | 7,089,007 | - | 6.7 | 76,326 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.22 per share. | 01 Oct 2024 | 11,447 | 7,098,428 | - | 6.2 | 71,150 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 2,026 | 7,100,454 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.84 per share. | 17 Sep 2024 | 11,447 | 7,109,875 | - | 6.8 | 78,333 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 03 Sep 2024 | 11,447 | 7,121,322 | - | 6.3 | 71,718 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.12 per share. | 20 Aug 2024 | 11,447 | 7,132,769 | - | 7.1 | 81,532 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.82 per share. | 06 Aug 2024 | 11,447 | 7,144,216 | - | 6.8 | 78,083 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.48 per share. | 23 Jul 2024 | 11,447 | 7,155,663 | - | 8.5 | 97,041 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.32 per share. | 09 Jul 2024 | 11,447 | 7,167,110 | - | 7.3 | 83,735 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,441 | 7,178,557 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 9.51 per share. | 25 Jun 2024 | 11,447 | 7,177,116 | - | 9.5 | 108,806 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.45 per share. | 11 Jun 2024 | 11,447 | 7,188,563 | - | 8.5 | 96,763 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 26,193 | 26,193 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 13,097 | 7,200,010 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 9.17 per share. | 28 May 2024 | 11,447 | 7,186,913 | - | 9.2 | 104,943 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 14 May 2024 | 20,054 | 7,198,360 | - | 10.1 | 202,934 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.95 per share. | 30 Apr 2024 | 11,447 | 7,218,414 | - | 7.9 | 90,964 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.66 per share. | 16 Apr 2024 | 11,447 | 7,229,861 | - | 7.7 | 87,725 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.82 per share. | 02 Apr 2024 | 11,447 | 7,241,308 | - | 8.8 | 100,942 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 10.79 per share. | 19 Mar 2024 | 20,054 | 7,252,755 | - | 10.8 | 216,423 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 05 Mar 2024 | 20,054 | 7,272,809 | - | 12.1 | 241,805 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Borgeson Blake | Director | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 20 Feb 2024 | 19,745 | 7,293,172 | - | 12.3 | 243,095 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 20 Feb 2024 | 309 | 7,292,863 | - | 13.0 | 4,030 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Borgeson Blake | Director | Sale of securities on an exchange or to another person at price $ 9.30 per share. | 06 Feb 2024 | 11,447 | 7,312,917 | - | 9.3 | 106,489 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 10.58 per share. | 23 Jan 2024 | 20,054 | 7,324,364 | - | 10.6 | 212,083 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Borgeson Blake | Director | Sale of securities on an exchange or to another person at price $ 13.81 per share. | 09 Jan 2024 | 13,751 | 7,344,418 | - | 13.8 | 189,925 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 09 Jan 2024 | 6,303 | 7,358,169 | - | 13.2 | 83,278 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 26 Dec 2023 | 20,054 | 7,364,472 | - | 10.6 | 213,144 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 12 Dec 2023 | 11,447 | 7,384,526 | - | 7.4 | 84,693 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 22 Aug 2023 | 8,885 | 7,460,730 | - | 8.9 | 79,181 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 08 Aug 2023 | 14,498 | 7,472,887 | - | 11.0 | 159,848 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 11.75 per share. | 08 Aug 2023 | 3,272 | 7,469,615 | - | 11.7 | 38,436 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.89 per share. | 11 Jul 2023 | 8,885 | 7,520,104 | - | 6.9 | 61,194 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 14.61 per share. | 29 Jun 2023 | 18,719 | 7,487,385 | - | 14.6 | 273,464 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jun 2023 | 14,000 | 7,506,104 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 27 Jun 2023 | 8,885 | 7,528,989 | - | 7.4 | 65,639 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 25,224 | 25,224 | - | - | Stock Option (Right to Buy | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 12,612 | 7,537,874 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 9.98 per share. | 13 Jun 2023 | 15,485 | 7,525,262 | - | 10.0 | 154,506 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.79 per share. | 30 May 2023 | 8,885 | 7,540,747 | - | 8.8 | 78,134 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 16 May 2023 | 8,885 | 7,549,632 | - | 5.1 | 45,241 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 5.93 per share. | 18 Apr 2023 | 8,885 | 7,558,517 | - | 5.9 | 52,730 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 04 Apr 2023 | 8,885 | 7,567,402 | - | 6.5 | 57,992 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 21 Mar 2023 | 8,885 | 7,576,287 | - | 7.4 | 65,744 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.33 per share. | 07 Mar 2023 | 8,885 | 7,585,172 | - | 8.3 | 73,989 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.73 per share. | 21 Feb 2023 | 8,885 | 7,594,057 | - | 7.7 | 68,708 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.81 per share. | 07 Feb 2023 | 8,885 | 7,602,942 | - | 8.8 | 78,263 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.71 per share. | 24 Jan 2023 | 8,885 | 7,611,827 | - | 8.7 | 77,368 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.69 per share. | 10 Jan 2023 | 8,885 | 7,620,712 | - | 7.7 | 68,283 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,325 | 7,629,597 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 7.25 per share. | 27 Dec 2022 | 8,885 | 7,628,272 | - | 7.2 | 64,373 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.96 per share. | 13 Dec 2022 | 8,885 | 7,637,157 | - | 9.0 | 79,598 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 29 Nov 2022 | 8,885 | 7,646,042 | - | 8.8 | 77,786 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 11.12 per share. | 16 Nov 2022 | 17,770 | 7,654,927 | - | 11.1 | 197,610 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 920 | 7,672,697 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 1,186 | 7,671,777 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 36,290 | 36,290 | - | - | Stock Option (right to buy) | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,145 | 7,670,591 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,300 | 7,652,446 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 03 Jan 2022 | 9,625 | 7,651,146 | - | 18.0 | 173,528 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 555 | 7,660,771 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 18.75 per share. | 21 Dec 2021 | 9,625 | 7,660,216 | - | 18.8 | 180,478 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 20.38 per share. | 07 Dec 2021 | 7,725 | 7,670,241 | - | 20.4 | 157,451 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 19.78 per share. | 07 Dec 2021 | 1,500 | 7,677,966 | - | 19.8 | 29,672 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 07 Dec 2021 | 400 | 7,669,841 | - | 21.0 | 8,411 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 19.05 per share. | 18 Nov 2021 | 7,725 | 7,679,466 | - | 19.1 | 147,194 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 18.32 per share. | 18 Nov 2021 | 1,900 | 7,687,191 | - | 18.3 | 34,811 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 457 | 7,689,091 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 278 | 7,688,634 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 7,688,356 | 7,688,356 | - | - | Class A Common Stock | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 7,688,356 | 0 | - | - | Common Stock | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 923,052 | 7,688,356 | - | - | Common Stock | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 544,743 | 0 | - | - | Series A-1 Preferred Stock | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 378,309 | 0 | - | - | Series A Preferred Stock | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | 20 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 6,250 | 6,765,304 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges